Literature DB >> 15777569

Evaluation and management of non-alcoholic steatohepatitis.

Seela Ramesh1, Arun J Sanyal.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15777569     DOI： 10.1016/j.jhep.2004.11.022

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  21 in total

Review 1.  Non-alcoholic fatty liver disease: The diagnosis and management.

Authors:  Shehab M Abd El-Kader; Eman M Salah El-Den Ashmawy
Journal:  World J Hepatol       Date:  2015-04-28

2.  Nonalcoholic fatty liver disease markers are associated with insulin resistance in type 1 diabetes.

Authors:  Tomislav Bulum; Branko Kolarić; Lea Duvnjak; Marko Duvnjak
Journal:  Dig Dis Sci       Date:  2011-07-07       Impact factor: 3.199

3.  Non-alcoholic fatty liver disease in the first trimester and subsequent development of gestational diabetes mellitus.

Authors:  Seung Mi Lee; Soo Heon Kwak; Ja Nam Koo; Ig Hwan Oh; Jeong Eun Kwon; Byoung Jae Kim; Sun Min Kim; Sang Youn Kim; Gyoung Min Kim; Sae Kyung Joo; Bo Kyung Koo; Sue Shin; Chanthalakeo Vixay; Errol R Norwitz; Chan-Wook Park; Jong Kwan Jun; Won Kim; Joong Shin Park
Journal:  Diabetologia       Date:  2018-11-23       Impact factor: 10.122

4.  Predictors of nonalcoholic steatohepatitis in obese children.

Authors:  Stacee Marie Lerret; Laura Garcia-Rodriguez; Joseph Skelton; Vincent Biank; Denise Kilway; Grzegorz Telega
Journal:  Gastroenterol Nurs       Date:  2011 Nov-Dec       Impact factor: 0.978

5.  Liver fibrosis in women with chronic hepatitis C: evidence for the negative role of the menopause and steatosis and the potential benefit of hormone replacement therapy.

Authors:  Liana Codes; Tarik Asselah; Dominique Cazals-Hatem; Florence Tubach; Dominique Vidaud; Raymundo Paraná; Pierre Bedossa; Dominique Valla; Patrick Marcellin
Journal:  Gut       Date:  2006-09-27       Impact factor: 23.059

6.  Hepatoprotective effects of Spirulina maxima in patients with non-alcoholic fatty liver disease: a case series.

Authors:  Aldo Ferreira-Hermosillo; Patricia V Torres-Duran; Marco A Juarez-Oropeza
Journal:  J Med Case Rep       Date:  2010-04-07

7.  Steatohepatitis: Risk factors and impact on disease severity in human immunodeficiency virus/hepatitis C virus coinfection.

Authors:  Richard K Sterling; Melissa J Contos; Paula G Smith; R Todd Stravitz; Velimir A Luketic; Michael Fuchs; Mitchell L Shiffman; Arun J Sanyal
Journal:  Hepatology       Date:  2008-04       Impact factor: 17.425

8.  Specific role for acyl CoA:Diacylglycerol acyltransferase 1 (Dgat1) in hepatic steatosis due to exogenous fatty acids.

Authors:  Claudio J Villanueva; Mara Monetti; Michelle Shih; Ping Zhou; Steve M Watkins; Sanjay Bhanot; Robert V Farese
Journal:  Hepatology       Date:  2009-08       Impact factor: 17.425

Review 9.  Mechanisms of intrahepatic triglyceride accumulation.

Authors:  Claudia Ress; Susanne Kaser
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

10.  Liver histology changes in nonalcoholic steatohepatitis after one year of treatment with probucol.

Authors:  Shahin Merat; Mohsen Aduli; Rozana Kazemi; Masoud Sotoudeh; Nahid Sedighi; Masoud Sohrabi; Reza Malekzadeh
Journal:  Dig Dis Sci       Date:  2007-11-30       Impact factor: 3.199
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.